infecti
agent
long
known
caus
acut
particularli
infant
young
howev
proport
adultp
clinic
symptom
typic
acut
enterocol
absenc
identifi
microbi
pathogen
failur
isol
pathogen
organ
infect
stool
patient
conclus
demonstr
ill
infecti
instanc
individu
may
infect
organ
clear
gut
time
sampl
obtain
test
costcontain
purpos
diagnost
laboratori
test
known
enteropathogen
focu
isol
procedur
organ
histor
identifi
commonli
local
commun
exampl
despit
increasingli
widespread
accept
enterohemorrhag
eschevichia
coli
recogn
caus
diseas
medic
center
commerci
laboratori
routin
test
organ
standard
stool
presenc
unrecogn
enteropathogen
may
provid
anwork
author
laboratori
support
medic
research
council
canada
nation
institut
health
philip
sherman
md
frcpc
recipi
career
scientist
award
ontario
ministri
health
explan
failur
identifi
infecti
agent
stool
exampl
campylobact
jejuni
campylobact
coli
infect
recogn
major
health
concern
organ
could
cultur
routin
select
medium
microaerophil
cultur
condit
select
media
use
contain
antibiot
suppress
growth
fecal
microflora
permit
replic
resist
campylobact
limit
techniqu
intestin
campylobact
sensit
antibiot
select
cultur
medium
identifi
exampl
campylobact
upsaliensi
like
import
caus
diseas
underdiagnos
standard
method
cultur
intestin
campylobact
use
antibiot
organ
sensit
lack
suitabl
cultur
techniqu
success
grow
microb
anoth
possibl
reason
failur
identifi
enteropathogen
polymeras
chain
reaction
pcr
use
identifi
noncultur
microbi
pathogen
includ
exampl
whippl
bacillu
intestin
biopsi
specimen
technolog
also
demonstr
microbi
pathogen
caus
gastric
diseas
absenc
enterocolit
symptom
review
highlight
select
recent
recogn
emerg
bacteri
viral
pathogen
infect
gastrointestin
tract
protozo
helminth
fungal
infect
consid
review
nevertheless
import
caus
diseas
involv
gastrointestin
tract
especi
immunocompromis
host
sever
agent
includ
cryptosporidia
microsporidia
cyclospora
possibl
dientamoeba
fiagili
blastocysti
homini
increasingli
recogn
human
enteropathogen
interest
reader
refer
accompani
articl
winter
chang
issu
sever
recent
relev
newli
recogn
agent
may
ultim
prove
true
caus
diseas
nevertheless
sever
consid
review
like
proven
import
gastroenter
pathogen
children
also
consid
emphas
much
remain
learn
interact
gastrointestin
tract
multitud
microb
enter
daili
basi
recent
review
provid
summari
therapeut
approach
acut
infecti
diarrhea
includ
importantli
oral
rehydr
therapi
futur
promis
develop
field
test
widespread
deliveri
mucos
vaccin
use
prevent
gastroenter
infect
helicobact
pylori
gastric
pathogen
first
success
cultur
mucos
biopsi
obtain
antrum
patient
earli
marshal
warren
perth
western
presenc
ureaseproduc
gramneg
microaerob
organ
correl
histopatholog
evid
chronicact
type
b
tabl
specif
infect
certain
subtyp
resolut
gastriti
antibacteri
induct
type
b
gastriti
human
volunteershx
appropri
experiment
fulfil
koch
postul
therebi
establish
h
pylori
human
pathogen
infect
stomach
also
strongli
correl
recur
peptic
ulcer
diseas
gastric
cancer
reader
refer
chapter
volum
detail
review
h
pylori
infect
helicobact
heilmannii
ureaseproduc
spiralshap
organ
also
associ
gastriti
antrum
infect
human
domest
anim
includ
shown
figur
organ
distinguish
h
pylori
brightfield
microscopi
use
transmiss
electron
microscopi
h
heilmannii
longer
tightli
coil
present
corkscrewlik
appear
formerli
refer
gastrospirillum
homini
h
heilmannii
identifi
inflam
antral
tissu
less
commonli
h
pylori
incid
infect
organ
like
underestim
cultur
l
n
organ
identifi
stain
silver
mucos
biopsi
stomach
children
adolesc
studi
need
determin
preval
h
heilmannii
infect
children
without
type
b
gastriti
adult
menetri
diseas
hypertroph
gastriti
chronic
remit
relaps
diseas
seem
relat
excess
product
transform
growth
factoralpha
gastric
mu
fig
obin
contrast
childhood
mhetrier
diseas
shortliv
acut
recent
suggest
infecti
etiolog
sever
investig
identifi
cytomegaloviru
cmv
virion
genom
dna
antral
mucosa
children
proteinlos
gastropathi
hypertroph
gastriti
characterist
mbnktrier
cluster
case
cmvassoci
mbnetrier
diseas
report
kovac
colleaguess
five
children
year
age
howev
restrict
enzym
dna
fingerprint
support
hypothesi
gastric
infect
due
singl
virul
strain
viru
fact
least
four
differ
cmv
strain
identifi
among
five
infant
past
year
seen
emerg
new
vibrio
cholera
serogroup
caus
epidem
diarrheal
diseas
primarili
indian
subcntin
although
lipopolysaccharid
henc
serogroup
strain
distinct
classic
epidem
strain
v
cholera
contain
virul
operon
ie
cholera
toxin
toxincoregul
pilu
organ
tradit
caus
worldwid
cholera
sever
dehydr
cholera
relat
gsproteinmedi
activ
cyclic
adenosin
monophosph
cholera
toxin
caus
reduc
sodiumchloridecoupl
absorpt
villu
enterocyt
increas
chlorid
secret
crypt
recent
studi
show
effect
mediat
enter
nervou
system
increasingli
complex
interact
nerv
muscl
mast
cell
cell
b
cell
host
epithelium
recogn
ultim
modul
host
respons
infect
organ
toxinslo
inde
concept
sponsor
format
new
multidisciplinari
field
investig
refer
neuroimmunodelet
gene
encod
activ
adenosin
phate
ribosyl
b
bind
subunit
cholera
toxin
attenu
complet
block
diarrheal
respons
infect
human
experiment
studi
use
anim
tissu
led
recognit
v
cholera
harbor
addit
virul
factor
bacteri
genom
may
contribut
diarrheal
diseas
serv
factor
requir
consider
design
option
nontox
vaccin
two
newli
recogn
toxin
produc
v
cholera
zona
occluden
toxin
zot
accessori
cholera
enterotoxin
ace
enteroaggreg
e
coli
eaggec
character
pattern
bacteri
adhes
infect
tissu
cultur
organ
produc
enterotoxin
heattabl
epidemiolog
studi
provid
support
evid
pathogen
role
eaggec
diseas
especi
caus
persist
diarrhea
studi
organ
identifi
stool
sampl
children
diarrhea
frequent
agematch
control
exampl
cravioto
identifi
eaggec
mexican
children
year
age
protract
diarrhea
asymptomat
agematch
infant
rel
import
eaggec
caus
diseas
unit
state
remain
establish
biolog
relev
vitro
adhes
properti
toxin
produc
bacteria
also
need
address
experiment
evalu
diffus
adher
e
coli
daec
character
bind
organ
evenli
surfac
tissu
cultur
cell
vitro
adhes
daec
associ
acut
chronic
diarrhea
casecontrol
epidemiolog
td
e
ho
reproduc
generaliz
find
need
defin
genet
probe
defin
bacteri
adhesin
help
achiev
goal
although
gener
consid
constitu
normal
colon
microflora
investig
report
toxinproduc
variant
bacteroid
fyagili
enteropathogen
addit
studi
requir
fulfil
koch
postul
organ
recognit
normal
constitu
fecal
flora
caus
diseas
howev
without
preced
exampl
clostvidiuvrz
difficil
part
normal
colon
microflora
toxinproduc
c
difficil
colon
normal
infant
without
appar
ill
effect
perhap
receptor
requir
bind
toxin
elabor
organ
present
later
alter
normal
flora
use
antibiot
creat
microenviron
organ
prolifer
suscept
ie
ageappropri
host
ultim
result
diseas
concept
commens
microflora
influenc
health
also
use
develop
medic
biotherapi
nonpathogen
organ
saccharomyc
boulavdii
bifdobactevium
bifdum
lactobacillu
speci
use
treat
prevent
infecti
enterocolitid
addit
rotavirus
adenovirus
serotyp
norwalk
viru
relat
nm
enteritisassoci
virus
recent
epidemiolog
studi
demonstr
astroviru
etiolog
agent
childhood
control
studi
thailand
use
monoclon
antibodybas
immunoassay
astroviru
detect
symptomat
children
compar
asymptomat
agematch
control
p
tabl
compar
find
report
daycar
center
north
america
recent
deriv
sequenc
astroviru
rna
genom
reveal
agent
suffici
uniqu
classifi
famili
atrovirida
rna
genom
norwalk
viru
sever
norwalklik
virus
also
term
small
round
structur
virus
srsv
caliciviru
equenc
rna
sequenc
virus
relat
agent
consid
member
famili
calicivirida
use
revers
transcriptionpcr
srsv
subclassifi
four
distinct
genotyp
also
identifi
differ
group
without
intestin
symptom
p
tdiffer
group
without
intestin
symptom
p
signific
immunoelectron
greatli
simplifi
understand
classif
agent
fring
pleomorph
particl
resembl
torovirus
first
report
stool
specimen
children
diarrhea
beard
pleomorph
structur
electron
microscopi
alon
suffici
convinc
agent
gain
immedi
accept
viral
enteropathogen
recent
find
toroviruslik
particl
reactiv
immunoassay
use
antiserum
wellestablish
morpholog
similar
breda
viru
calv
provid
support
evid
particl
inde
preliminari
evid
show
toroviruslik
particl
fig
also
may
report
coronaviruslik
agent
commonli
found
stool
sampl
children
period
begin
octob
toroviruslik
particl
account
half
stool
specimen
posit
virus
examin
electron
contrast
toroviru
identifi
stool
specimen
obtain
agematch
children
without
intestin
symptom
addit
investig
multipl
center
requir
confirm
enteropathogen
torovirus
clarifi
epidemiolog
infect
intestin
spirochetosi
refer
colon
larg
bowel
mucosa
brachyspira
aalborgi
relat
spirochet
organ
identifi
biopsi
colon
mucosa
obtain
colonoscopi
fig
although
investig
report
spirochet
caus
bloodi
appropri
control
studi
perform
ascertain
preval
aalbovgi
adher
colon
mucosa
asymptomat
children
fact
studi
adult
indic
asymptomat
colon
larg
bowel
addit
studi
character
presenc
potenti
virul
properti
toxin
product
invas
potenti
abil
induc
signal
transduct
respons
follow
adhes
colonocyt
clearli
warrant
enterohemorrhag
e
coli
ehec
refer
e
coli
limit
number
serotyp
includ
hll
bacteria
caus
hemorrhag
coliti
system
complic
includ
hemolyt
urem
syndrom
ie
microangiopath
hemolyt
anemia
thrombocytopenia
renal
failur
thrombot
thrombocytopen
purpura
ie
microangiopathi
neurolog
involv
morbid
mortal
immens
financi
implic
foodborn
infect
fulli
hemorrhag
coliti
system
complic
diseas
also
caus
infect
e
coli
serotyp
albeit
less
frequent
strain
character
product
one
phageencod
cytotoxin
various
refer
shigalik
toxin
verocytotoxin
toxin
function
nglycosidas
depurin
specif
residu
adenin
ribosom
rna
therebi
block
eukaryot
cell
protein
synthesi
ultim
result
cell
precis
role
cytotoxin
ehecinduc
diseas
current
activ
investig
studi
use
anim
model
report
evid
role
verocytotoxin
experiment
induc
enterocol
toxin
import
begin
cascad
result
system
diseas
prevent
toxin
bind
enterocyt
receptor
may
interrupt
pathophysiolog
diseas
hypothesi
receptor
analog
therapi
effect
safe
form
treatment
prevent
system
complic
ehec
infect
novel
treatment
approach
requir
antimicrobi
agent
unproven
benefit
theoret
antibiot
could
caus
harm
cytotoxin
releas
periplasm
organ
follow
exposur
agent
disrupt
prokaryot
outer
membran
increas
preval
antibiot
resist
among
ehec
isol
also
recent
ec
r
b
e
ehec
attach
infect
epitheli
cell
vitro
experiment
anim
morpholog
distinct
pattern
refer
attach
effac
adhes
fig
lo
attach
effac
lesion
depend
chromosom
encod
bacteri
outer
membran
protein
role
outer
membran
protein
mediat
ehecinduc
diarrheal
diseas
activ
investig
adhesin
potenti
vaccin
candid
whether
cytotoxinproduc
strain
induc
attach
effac
lesion
doubt
author
report
exampl
verocytotoxinproduc
e
coli
serotyp
contain
homolog
gene
outer
membran
adhesin
caus
attach
effac
adhes
either
vitro
typic
infecti
coliti
lamina
propria
larg
intestin
infiltr
polymorphonuclear
leukocyt
follow
ehec
infect
use
lapin
model
elliot
show
mono
clonal
antibodi
vascular
adhes
epitop
leukocyt
reduc
secretori
respons
colon
e
coli
infect
thu
antiinflammatori
molecul
might
serv
provid
novel
therapi
regardless
role
cytotoxin
outer
membran
protein
etiopathogenesi
ehec
infect
recognit
bacteri
infect
induc
signal
transduct
respons
infect
epitheli
cell
also
provid
new
avenu
consid
novel
form
therapi
exampl
chemokin
attract
neutrophil
site
mucos
infect
produc
epitheli
cell
origin
respons
bacteri
infect
inhibitor
chemokin
product
inhibit
biolog
effect
neutrophil
chemoattract
potenti
reduc
mucos
inflammatori
respons
attend
clinic
sequela
eukaryot
cell
also
respond
infect
elev
cytosol
second
messeng
includ
inositol
triphosph
ip
calcium
caz
intestin
epithelium
second
messeng
mediat
diarrheal
respons
infectin
calciumcalmodulin
inhibitor
may
benefici
effect
treat
gastrointestin
infect
mediat
chang
level
cytosol
free
calcium
dupont
show
exampl
oral
therapi
zaldarid
maleat
reliev
symptom
diseas
shorten
durat
diarrhea
travel
etecinduc
diarrhea
evalu
addit
signal
transduct
respons
microbi
infect
provid
new
insight
pathogenesi
gastrointestin
infecti
diseas
novel
approach
consid
prevent
therapi
human
ill
